161 related articles for article (PubMed ID: 12441358)
1. A single mutation in the 5-HT4 receptor (5-HT4-R D100(3.32)A) generates a Gs-coupled receptor activated exclusively by synthetic ligands (RASSL).
Claeysen S; Joubert L; Sebben M; Bockaert J; Dumuis A
J Biol Chem; 2003 Jan; 278(2):699-702. PubMed ID: 12441358
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological properties of 5-Hydroxytryptamine(4) receptor antagonists on constitutively active wild-type and mutated receptors.
Claeysen S; Sebben M; Bécamel C; Eglen RM; Clark RD; Bockaert J; Dumuis A
Mol Pharmacol; 2000 Jul; 58(1):136-44. PubMed ID: 10860935
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological profile of engineered 5-HT₄ receptors and identification of 5-HT₄ receptor-biased ligands.
Gaven F; Pellissier LP; Queffeulou E; Cochet M; Bockaert J; Dumuis A; Claeysen S
Brain Res; 2013 May; 1511():65-72. PubMed ID: 23148949
[TBL] [Abstract][Full Text] [Related]
4. Engineering the melanocortin-4 receptor to control G(s) signaling in vivo.
Srinivasan S; Vaisse C; Conklin BR
Ann N Y Acad Sci; 2003 Jun; 994():225-32. PubMed ID: 12851320
[TBL] [Abstract][Full Text] [Related]
5. A 5-HT4 receptor transmembrane network implicated in the activity of inverse agonists but not agonists.
Joubert L; Claeysen S; Sebben M; Bessis AS; Clark RD; Martin RS; Bockaert J; Dumuis A
J Biol Chem; 2002 Jul; 277(28):25502-11. PubMed ID: 11976337
[TBL] [Abstract][Full Text] [Related]
6. Modifying ligand-induced and constitutive signaling of the human 5-HT4 receptor.
Chang WC; Ng JK; Nguyen T; Pellissier L; Claeysen S; Hsiao EC; Conklin BR
PLoS One; 2007 Dec; 2(12):e1317. PubMed ID: 18338032
[TBL] [Abstract][Full Text] [Related]
7. Ras-dependent ERK activation by the human G(s)-coupled serotonin receptors 5-HT4(b) and 5-HT7(a).
Norum JH; Hart K; Levy FO
J Biol Chem; 2003 Jan; 278(5):3098-104. PubMed ID: 12446729
[TBL] [Abstract][Full Text] [Related]
8. G protein activation by serotonin type 4 receptor dimers: evidence that turning on two protomers is more efficient.
Pellissier LP; Barthet G; Gaven F; Cassier E; Trinquet E; Pin JP; Marin P; Dumuis A; Bockaert J; Banères JL; Claeysen S
J Biol Chem; 2011 Mar; 286(12):9985-97. PubMed ID: 21247891
[TBL] [Abstract][Full Text] [Related]
9. Related GPCRs couple differently to G
Andressen KW; Ulsund AH; Krobert KA; Lohse MJ; Bünemann M; Levy FO
FASEB J; 2018 Feb; 32(2):1059-1069. PubMed ID: 29079700
[TBL] [Abstract][Full Text] [Related]
10. A G(q/11)-coupled mutant histamine H(1) receptor F435A activated solely by synthetic ligands (RASSL).
Bruysters M; Jongejan A; Akdemir A; Bakker RA; Leurs R
J Biol Chem; 2005 Oct; 280(41):34741-6. PubMed ID: 16027157
[TBL] [Abstract][Full Text] [Related]
11. Developing chemical genetic approaches to explore G protein-coupled receptor function: validation of the use of a receptor activated solely by synthetic ligand (RASSL).
Alvarez-Curto E; Prihandoko R; Tautermann CS; Zwier JM; Pediani JD; Lohse MJ; Hoffmann C; Tobin AB; Milligan G
Mol Pharmacol; 2011 Dec; 80(6):1033-46. PubMed ID: 21880827
[TBL] [Abstract][Full Text] [Related]
12. 5HT4(a) and 5-HT4(b) receptors have nearly identical pharmacology and are both expressed in human atrium and ventricle.
Bach T; Syversveen T; Kvingedal AM; Krobert KA; Brattelid T; Kaumann AJ; Levy FO
Naunyn Schmiedebergs Arch Pharmacol; 2001 Feb; 363(2):146-60. PubMed ID: 11218067
[TBL] [Abstract][Full Text] [Related]
13. Serotonin 5-HT3 and 5-HT4 ligands: an update of medicinal chemistry research in the last few years.
Modica MN; Pittalà V; Romeo G; Salerno L; Siracusa MA
Curr Med Chem; 2010; 17(4):334-62. PubMed ID: 20015043
[TBL] [Abstract][Full Text] [Related]
14. Mutation in a protein kinase C phosphorylation site of the 5-HT1A receptor preferentially attenuates Ca2+ responses to partial as opposed to higher-efficacy 5-HT1A agonists.
Wurch T; Colpaert FC; Pauwels PJ
Neuropharmacology; 2003 Jun; 44(7):873-81. PubMed ID: 12726819
[TBL] [Abstract][Full Text] [Related]
15. Serotonin (5-HT) receptor subtypes mediate specific modes of 5-HT-induced signaling and regulation of neurosecretion in gonadotropin-releasing hormone neurons.
Wada K; Hu L; Mores N; Navarro CE; Fuda H; Krsmanovic LZ; Catt KJ
Mol Endocrinol; 2006 Jan; 20(1):125-35. PubMed ID: 16109737
[TBL] [Abstract][Full Text] [Related]
16. Mutant 5-hydroxytryptamine 1A receptor D116A is a receptor activated solely by synthetic ligands with a rich pharmacology.
Cussac D; Palmier C; Finana F; De Vries L; Tardif S; Léger C; Bernois S; Heusler P
J Pharmacol Exp Ther; 2009 Oct; 331(1):222-33. PubMed ID: 19605522
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological characterization of 5-HT4 receptors mediating relaxation of canine isolated rectum circular smooth muscle.
Prins NH; Van Haselen JF; Lefebvre RA; Briejer MR; Akkermans LM; Schuurkes JA
Br J Pharmacol; 1999 Jul; 127(6):1431-7. PubMed ID: 10455293
[TBL] [Abstract][Full Text] [Related]
18. Molecular and behavioral effects mediated by Gs-coupled adenosine A2a, but not serotonin 5-Ht4 or 5-Ht6 receptors following antipsychotic administration.
Ward RP; Dorsa DM
Neuroscience; 1999 Mar; 89(3):927-38. PubMed ID: 10199625
[TBL] [Abstract][Full Text] [Related]
19. [3H]5-hydroxytryptamine labels the agonist high affinity state of the cloned rat 5-HT4 receptor.
Adham N; Gerald C; Schechter L; Vaysse P; Weinshank R; Branchek T
Eur J Pharmacol; 1996 May; 304(1-3):231-5. PubMed ID: 8813606
[TBL] [Abstract][Full Text] [Related]
20. GPCRs steer G
Huang S; Xu P; Shen DD; Simon IA; Mao C; Tan Y; Zhang H; Harpsøe K; Li H; Zhang Y; You C; Yu X; Jiang Y; Zhang Y; Gloriam DE; Xu HE
Mol Cell; 2022 Jul; 82(14):2681-2695.e6. PubMed ID: 35714614
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
